{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:08:46Z","timestamp":1787771326945,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xi'an Science and Technology Plan Project","award":["22YXYJ0122"],"award-info":[{"award-number":["22YXYJ0122"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71096-w","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T17:02:21Z","timestamp":1724778141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Low muscle quality index is associated with increased risk of advanced fibrosis in adult patients with nonalcoholic fatty liver disease: NHANES 2011\u20132014"],"prefix":"10.1038","volume":"14","author":[{"given":"Xinxing","family":"Tantai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Tuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shejiao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"71096_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review. Hepatology 77, 1335\u20131347 (2023).","journal-title":"Hepatology"},{"key":"71096_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12072-018-09926-z","volume":"13","author":"D Kim","year":"2019","unstructured":"Kim, D. et al. Race\/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005\u20132016. Hepatol Int. 13, 205\u2013213 (2019).","journal-title":"Hepatol Int."},{"key":"71096_CR3","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","volume":"113","author":"M Noureddin","year":"2018","unstructured":"Noureddin, M. et al. NASH leading cause of liver transplant in women: Updated analysis of indications for liver transplant and ethnic and gender variances. Am. J. Gastroenterol. 113, 1649\u20131659 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"71096_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/hep.28376","volume":"63","author":"YH Lee","year":"2016","unstructured":"Lee, Y. H. et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008\u20132011). Hepatology 63, 776\u2013786 (2016).","journal-title":"Hepatology"},{"key":"71096_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/jcsm.13125","volume":"14","author":"HJ Choe","year":"2023","unstructured":"Choe, H. J. et al. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort. J. Cachexia Sarcopenia Muscle 14, 260\u2013269 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"71096_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s40279-015-0305-z","volume":"45","author":"MS Fragala","year":"2015","unstructured":"Fragala, M. S. et al. Muscle quality in aging: a multi-dimensional approach to muscle functioning with applications for treatment. Sports Med. 45, 641\u2013658 (2015).","journal-title":"Sports Med."},{"key":"71096_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl, C. E. et al. Everhart, fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol. Ther. 41, 65\u201376 (2015).","journal-title":"Aliment Pharmacol. Ther."},{"key":"71096_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig. Liver Dis. 42, 503\u2013508 (2010).","journal-title":"Dig. Liver Dis."},{"key":"71096_CR9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo, P. et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846\u2013854 (2007).","journal-title":"Hepatology"},{"key":"71096_CR10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah, A. G. et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 7, 1104\u20131112 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"71096_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai, C. T. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38, 518\u2013526 (2003).","journal-title":"Hepatology"},{"key":"71096_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/apt.17308","volume":"57","author":"A Henry","year":"2023","unstructured":"Henry, A. et al. Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). Aliment Pharmacol. Ther. 57, 709\u2013722 (2023).","journal-title":"Aliment Pharmacol. Ther."},{"key":"71096_CR13","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/j.cgh.2021.11.029","volume":"20","author":"A Kardashian","year":"2022","unstructured":"Kardashian, A. et al. Food insecurity is associated with mortality among U.S. adults with nonalcoholic fatty liver disease and advanced fibrosis. Clin. Gastroenterol. Hepatol. 20, 2790-2799.e2794 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"71096_CR14","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/hep.31158","volume":"72","author":"D Kim","year":"2020","unstructured":"Kim, D., Vazquez-Montesino, L. M., Li, A. A., Cholankeril, G. & Ahmed, A. Inadequate physical activity and sedentary behavior are independent predictors of nonalcoholic fatty liver disease. Hepatology 72, 1556\u20131568 (2020).","journal-title":"Hepatology"},{"key":"71096_CR15","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.clnu.2022.04.026","volume":"41","author":"LCC Lopes","year":"2022","unstructured":"Lopes, L. C. C. et al. Sex and population-specific cutoff values of muscle quality index: Results from NHANES 2011\u20132014. Clin. Nutr. 41, 1328\u20131334 (2022).","journal-title":"Clin. Nutr."},{"key":"71096_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.15585\/mmwr.mm6706a3","volume":"67","author":"CL Ogden","year":"2018","unstructured":"Ogden, C. L. et al. Prevalence of obesity among youths by household income and education level of head of household\u2014United States 2011\u20132014. MMWR Morb. Mortal Wkly. Rep. 67, 186\u2013189 (2018).","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"71096_CR17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.2337\/dc20-1760","volume":"44","author":"AA Kammerlander","year":"2021","unstructured":"Kammerlander, A. A. et al. Association of metabolic phenotypes with coronary artery disease and cardiovascular events in patients with stable chest pain. Diabetes Care 44, 1038\u20131045 (2021).","journal-title":"Diabetes Care"},{"key":"71096_CR18","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1001\/jama.2018.14854","volume":"320","author":"KL Piercy","year":"2018","unstructured":"Piercy, K. L. et al. The physical activity guidelines for Americans. Jama 320, 2020\u20132028 (2018).","journal-title":"Jama"},{"key":"71096_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12603-012-0004-5","volume":"16","author":"S Barbat-Artigas","year":"2012","unstructured":"Barbat-Artigas, S. et al. Aubertin-Leheudre, How to assess functional status: A new muscle quality index. J. Nutr. Health Aging 16, 67\u201377 (2012).","journal-title":"J. Nutr. Health Aging"},{"key":"71096_CR20","doi-asserted-by":"publisher","first-page":"afae052","DOI":"10.1093\/ageing\/afae052","volume":"53","author":"B Kirk","year":"2024","unstructured":"Kirk, B. et al. The conceptual definition of sarcopenia: Delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing 53, afae052 (2024).","journal-title":"Age Ageing"},{"key":"71096_CR21","first-page":"349","volume":"11","author":"SW Son","year":"2021","unstructured":"Son, S. W. et al. Definition of sarcopenia in chronic liver disease. Life (Basel) 11, 349 (2021).","journal-title":"Life (Basel)"},{"key":"71096_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/nu15040891","volume":"15","author":"M Iwaki","year":"2023","unstructured":"Iwaki, M. et al. Impact of sarcopenia on non-alcoholic fatty liver disease. Nutrients 15, 891 (2023).","journal-title":"Nutrients"},{"key":"71096_CR23","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1016\/j.cgh.2023.02.013","volume":"21","author":"M Harring","year":"2023","unstructured":"Harring, M. et al. Sarcopenia among patients with nonalcoholic fatty liver disease (NAFLD) is associated with advanced fibrosis. Clin. Gastroenterol. Hepatol. 21, 2876-2888.e2875 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"71096_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.7570\/jomes.2019.28.2.129","volume":"28","author":"GE Chung","year":"2019","unstructured":"Chung, G. E. et al. Sarcopenia is significantly associated with presence and severity of nonalcoholic fatty liver disease. J. Obes. Metab. Syndr. 28, 129\u2013138 (2019).","journal-title":"J. Obes. Metab. Syndr."},{"key":"71096_CR25","doi-asserted-by":"publisher","first-page":"971913","DOI":"10.3389\/fnut.2022.971913","volume":"9","author":"ZH Zhao","year":"2022","unstructured":"Zhao, Z. H. et al. Assessing causal relationships between sarcopenia and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study. Front. Nutr. 9, 971913 (2022).","journal-title":"Front. Nutr."},{"key":"71096_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.cgh.2022.01.020","volume":"21","author":"YC Hsieh","year":"2023","unstructured":"Hsieh, Y. C. et al. Myosteatosis, but not sarcopenia, predisposes NAFLD subjects to early steatohepatitis and fibrosis progression. Clin. Gastroenterol. Hepatol. 21, 388-397.e310 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"71096_CR27","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/jcsm.12598","volume":"11","author":"S Kang","year":"2020","unstructured":"Kang, S. et al. Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: A Korean nationwide survey. J. Cachexia Sarcopenia Muscle 11, 1232\u20131241 (2020).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"71096_CR28","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.clnu.2019.01.028","volume":"38","author":"E Poggiogalle","year":"2019","unstructured":"Poggiogalle, E. et al. The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity. Clin. Nutr. 38, 2430\u20132435 (2019).","journal-title":"Clin. Nutr."},{"key":"71096_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.annepidem.2016.07.006","volume":"26","author":"JC Brown","year":"2016","unstructured":"Brown, J. C. et al. The muscle quality index and mortality among males and females. Ann. Epidemiol. 26, 648\u2013653 (2016).","journal-title":"Ann. Epidemiol."},{"key":"71096_CR30","doi-asserted-by":"publisher","first-page":"111469","DOI":"10.1016\/j.nut.2021.111469","volume":"93","author":"LCC Lopes","year":"2022","unstructured":"Lopes, L. C. C. et al. Low hand grip strength is associated with worse functional capacity and higher inflammation in people receiving maintenance hemodialysis. Nutrition 93, 111469 (2022).","journal-title":"Nutrition"},{"key":"71096_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.7570\/jomes23072","volume":"33","author":"N Oshida","year":"2024","unstructured":"Oshida, N. et al. Muscle quality as a potential diagnostic marker of advanced liver fibrosis in patients with non-alcoholic fatty liver disease. J. Obes. Metab. Syndr. 33, 143\u2013154 (2024).","journal-title":"J. Obes. Metab. Syndr."},{"key":"71096_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/apt.17601","volume":"58","author":"YK Lee","year":"2023","unstructured":"Lee, Y. K. et al. Low-quality muscle mass rather than normal-quality muscle mass determines fibrosis progression in biopsy-proven NAFLD. Aliment Pharmacol. Ther. 58, 322\u2013333 (2023).","journal-title":"Aliment Pharmacol. Ther."},{"key":"71096_CR33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jhep.2021.02.037","volume":"75","author":"M Nachit","year":"2021","unstructured":"Nachit, M. et al. Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity. J. Hepatol. 75, 292\u2013301 (2021).","journal-title":"J. Hepatol."},{"key":"71096_CR34","doi-asserted-by":"publisher","first-page":"e0196235","DOI":"10.1371\/journal.pone.0196235","volume":"13","author":"C Stretch","year":"2018","unstructured":"Stretch, C. et al. Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas. PLoS One 13, e0196235 (2018).","journal-title":"PLoS One"},{"key":"71096_CR35","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3389\/fphys.2020.00963","volume":"11","author":"R Correa-de-Araujo","year":"2020","unstructured":"Correa-de-Araujo, R. et al. Myosteatosis in the context of skeletal muscle function deficit: An interdisciplinary workshop at the National Institute on Aging. Front. Physiol. 11, 963 (2020).","journal-title":"Front. Physiol."},{"key":"71096_CR36","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","volume":"80","author":"SJ Song","year":"2024","unstructured":"Song, S. J. et al. Can we use old NAFLD data under the new MASLD definition?. J. Hepatol. 80, e54\u2013e56 (2024).","journal-title":"J. Hepatol."},{"key":"71096_CR37","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1016\/j.jhep.2023.08.025","volume":"80","author":"H Perazzo","year":"2024","unstructured":"Perazzo, H. et al. Changing from NAFLD through MAFLD to MASLD: Similar prevalence and risk factors in a large Brazilian cohort. J. Hepatol. 80, e72\u2013e74 (2024).","journal-title":"J. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71096-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71096-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71096-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T17:04:38Z","timestamp":1724778278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71096-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71096"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71096-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3958902\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study protocol was reviewed and approved by NCHS Ethics Review Board, approval number (Protocol #2011-17). Written informed consent was collected from all participants enrolled in the National Health and Nutrition Examination Survey. Further details can be found at\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"19883"}}